test

Intra-Operative Specimen Imaging in Breast Cancer Patients Undergoing Standard Partial Mastectomy: A Pilot of the Faxitron BioVision Wedge 3D versus BioVision 2D Imaging

Conditions

Breast Cancer | Cancer

Trial Phase

Phase Pilot

Trial Purpose and Description

Trial Purpose

The purpose of the study is to determine whether the BioVision Wedge 3D vs. BioVision 2D intraoperative specimen imaging in breast cancer patients undergoing needle localized partial mastectomy, will result in more optimal surgical treatment as defined by lower positive margin rates.


Participation Guidelines

Age:
18 Years and older
Gender:
Female

Eligibility Criteria

Inclusion Criteria:

  • Breast cancer, stage 0-3, deemed a surgically appropriate candidate for a needle localized partial mastectomy with planned procedure for the same
  • Women Age 18 years of age.
  • Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

  • Total mastectomy.
  • Known metastatic disease.
Sponsor:
Faxitron Bioptics, LLC
Dates:
07/25/2013
Last Updated:
Study HIC#:
1304011815